Nanobac Pharmaceuticals Inc. Engages Legal Team to Enforce Patent Rights
2008年2月7日 - 11:15PM
ビジãƒã‚¹ãƒ¯ã‚¤ãƒ¤ï¼ˆè‹±èªžï¼‰
Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the
Company�) is pleased to announce that it has engaged Guy
Ricciardulli for services related to claims for damages, injury or
loss out of patent infringement. �We are pleased to have Guy and
his exceptional team working with us on protecting our intellectual
property estate,� stated John Stanton, Nanobac�s Chairman and CEO.
�We are at a true turning point at Nanobac with our science, our
products and our partnerships, and we need to protect our
intellectual property estate.� Nanobac Pharmaceuticals Inc. is
headquartered in Tampa, Florida. For more information, visit our
website at: http://www.nanobac.com. Investors are cautioned that
certain statements in this document, some statements in periodic
press releases and some oral statements of Nanobac Pharmaceuticals,
Inc. officials are "Forward-Looking Statements" within the meaning
of the Private Securities Litigation Reform Act of 1995 (the
"Act"). Forward-Looking statements include statements which are
predictive in nature, which depend upon or refer to future events
or conditions, which include words such as "believes,"
"anticipates," "intends," "plans," "expects," and similar
expressions. In addition, any statements concerning future
financial performance (including future revenues, earnings or
growth rates), ongoing business strategies or prospects, and
possible future Nanobac Pharmaceuticals, Inc. actions, which may be
provided by management, are also forward-looking statements as
defined by the Act. Forward-Looking statements involve known and
unknown risks, uncertainties, and other factors which may cause the
actual results, performance or achievements of the Company to
materially differ from any future results, performance or
achievements expressed or implied by such forward-looking
statements and to vary significantly from reporting period to
reporting period. Although management believes that the assumptions
will, in fact, prove to be correct or that actual future results
will not be different from the expectations expressed in this
report. These statements are not guarantees of future performance
and Nanobac Pharmaceuticals, Inc. has no specific intention to
update these statements.
Nanobac Pharmaceuticals (CE) (USOTC:NNBP)
éŽåŽ» æ ªä¾¡ãƒãƒ£ãƒ¼ãƒˆ
ã‹ã‚‰ 11 2024 ã¾ã§ 12 2024
Nanobac Pharmaceuticals (CE) (USOTC:NNBP)
éŽåŽ» æ ªä¾¡ãƒãƒ£ãƒ¼ãƒˆ
ã‹ã‚‰ 12 2023 ã¾ã§ 12 2024
Real-Time news about Nanobac Pharmaceuticals Inc (CE) (ãã®ä»–OTC): 0 recent articles
ãã®ä»–ã®Nanobac Pharmaceuticals Inc.ニュース記事